Files
Download Full Text (347 KB)
Description
Background: Deaths from opiate overdose remain a persistent public health crisis. Of the 11,557 patients discharged from the Emergency Department (ED) with non-fatal opioid overdose, one year mortality shows 5.5% died within one year; 20.5% died within the first month; 22.4% died within the first two days. Naloxone can rapidly reverse fatal overdose and reduce mortality when available in the community. Identify people at risk for overdose, intervene to reduce future harm, and consistently offer naloxone at discharge while promoting health, well-being, and recovery. By December 1, 2023, >75% of patients aged 12 and older seeking care in the ED with opioid use disorder (OUD), opioid overdose or withdrawals will receive a naloxone kit or prescription at discharge. Plan/Current State: November 2022, Henry Ford Health System (HFHS) in conjunction with Michigan Emergency Improvement Collaborative (MEDIC) & Opioid Prescribing Engagement Network (OPEN) began collecting data on those at risk of opioid overdose. ED clinicians can prescribe or offer a naloxone take home kit (see Figure 1) for high-risk patients, and provide education on use to patient/caregiver; encourages patient to teach others how to use kit and where it is stored. From November 2022 to September 2023, approximately 42% of these patients were offered naloxone at discharge. Implementation of a Best Practice Advisory (BPA) alert within the electronic medical record (EMR) can increase the amount of naloxone distributed at discharge.
Publication Date
3-12-2024
Publisher
Henry Ford Health
City
Detroit, Michigan
Keywords
Quality Expo, posters, poster competition
Recommended Citation
Faraone, Heather; Fagan, Thomas; Joseph, John; Miller, Joe; MacDonald, Nancy; and Manteuffel, Jacob, "Project #44: OPIOID HARM REDUCTION: Increasing Naloxone Distribution at ED Discharge" (2024). Quality Expo 2024. 45.
https://scholarlycommons.henryford.com/qualityexpo2024/45
